Effects of Breaking up Prolonged Sitting on Postprandial Cardiometabolic Disease Risk Markers in South Asian Adults

April 19, 2026 updated by: Dr Daniel Bailey, University of Bedfordshire

Effects of Breaking up Prolonged Sitting on Postprandial Cardiometabolic Disease Risk Markers in Normal Weight Versus Overweight and Obese South Asian Adults

The purpose of this study is to examine whether breaking up prolonged sitting with short regular bouts of walking can reduce blood sugar and cholesterol levels after eating, which are risk markers for Type 2 diabetes and heart disease. This study will compare these responses in normal-weight versus overweight/obese South Asian adults.

Study Overview

Detailed Description

Participants will attend a preliminary testing session where height, weight, body fat and waist circumference will be measured. They will be familiarised with a motorised treadmill that will be used during the experimental visit below and will take part in an exercise test to determine a light-intensity walking speed for the experimental visit.

Participants will then attend two experimental visits in a random order:

  1. Prolonged sitting (SIT): Participants will remain seated for 5 hours and instructed to reduce excessive movement.
  2. Breaking up sitting with walking breaks (INT-SIT): Participants will rise from the seated position every 30 minutes throughout the experimental period to walk on a motorised treadmill at a light intensity for 5 minutes. After performing walking activity, they will return to the seated position. In addition, blood sample will be taken at the resting position just before each physical activity bout. The activity breaks will be undertaken on 9 occasions, providing a total of 45 min of light-intensity activity.

During each visit, blood pressure will be taken 11 times and blood samples will be taken 10 times. Participants will be given a breakfast and lunch meal to consume.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bedfordshire
      • Bedford, Bedfordshire, United Kingdom, MK41 9EA
        • University of Bedfordshire

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Self-identified South Asian ethnicity.
  • Self-report sitting at least 7 hours per day.
  • Normal weight, overweight or obese.

Exclusion Criteria:

  • Unable to speak and read English.
  • Contraindications to performing light-intensity walking.
  • Diagnosed cardiovascular disease or diabetes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prolonged sitting (SIT), then breaking up sitting with walking breaks (INT-SIT)

Firstly, participants will remain seated for 5 h and instructed to reduce excessive movement, only rising from the chair to void. After a washout period of at least 3 days, they then performed the INT-SIT condition.

Prolonged sitting (SIT): See SIT arm description Breaking up sitting with walking breaks (INT-SIT): See INT-SIT arm description

See Prolonged sitting arm description
Experimental: Breaking up sitting with walking breaks (INT-SIT), then prolonged sitting (SIT)

Firstly, participants will rise from the seated position every 30 min throughout the experimental period to walk on a motorised treadmill at a light intensity walking (as determined during the preliminary test) for 5 min. Participants will start walk on a treadmill at 30 min (so physical activity would be at 30-35 min), 60 min (physical activity will be at 60-65 min), 90 min (physical activity will be at 90-95 min), 120 min (physical activity will be 120-125 min), 150 min (physical activity will be at 150-155 min ), and 180 min (physical activity will be at 180-185 min) in the breakfast postprandial period and 30 min (physical activity will be 30-35 min), 60 min (physical activity will be at 60-65 min), and 90 min (physical activity will be at 90-95 min) in the lunch postprandial period. After performing a walking activity, they will return to the seated position. After a washout period of at least 3 days, they then performed the SIT condition.

SIT : See SIT arm description

See Breaking up sitting with walking breaks arm description

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial Glucose
Time Frame: Measured over the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for glucose
Measured over the 5 hour condition period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial Triglycerides
Time Frame: Measured over the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for triglycerides
Measured over the 5 hour condition period
Postprandial Insulin
Time Frame: Measured over the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for insulin
Measured over the 5 hour condition period
Metabolic Load Index
Time Frame: Measured over the 5 hour condition period

Incremental area under the curve for each 5 h condition will be calculated for the Metabolic Load Index (MLI).

The MLI will be calculated using the following equation:

MLI (mmol.L-1) = blood glucose (mmol.L-1) + TAG (mmol.L-1). Lower values of MLI are considered better for cardiometabolic health!

Measured over the 5 hour condition period
Resting Energy Expenditure
Time Frame: Measured for the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for resting energy expenditure
Measured for the 5 hour condition period
Resting Fat Oxidation
Time Frame: Measured for the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for resting fat oxidation
Measured for the 5 hour condition period
Resting Carbohydrate Oxidation
Time Frame: Measured for the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for resting carbohydrate oxidation
Measured for the 5 hour condition period
Mean Arterial Pressure
Time Frame: Measured over the 5 hour condition period

Mean Arterial Pressure (MAP) over the 5 h conditions.

The following formula will be used to calculate MAP, where P is blood pressure (systolic or diastolic):

MAP = PDiastolic + 1/3 (PSystolic - PDiastolic).

Measured over the 5 hour condition period
Heart Rate
Time Frame: Measured over the 5 hour condition period
Mean heart rate over the 5 h conditions
Measured over the 5 hour condition period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 26, 2019

Primary Completion (Actual)

March 20, 2020

Study Completion (Actual)

March 20, 2020

Study Registration Dates

First Submitted

March 28, 2019

First Submitted That Met QC Criteria

March 28, 2019

First Posted (Actual)

April 1, 2019

Study Record Updates

Last Update Posted (Actual)

April 21, 2026

Last Update Submitted That Met QC Criteria

April 19, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Prolonged sitting (SIT)

Subscribe